Gene · 246100
Papers4,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-testis antigens (CTAs) in lung cancer. | Clin Chim Acta | 2026 | 41176051 | PubTator, text mining | PubMed |
| CD8 co-receptor modulates the specificity profile of the 1G4 TCR against NY-ESO-1. | Mol Ther | 2026 | 41058174 | PubTator, text mining | PubMed |
| mRNA vaccines transform personalized lung cancer treatment. | Front Immunol | 2025 | 41766818 | PubTator, text mining | PubMed |
| In silico design of a multi-epitope vaccine against the triple negative breast cancer. | Sci Rep | 2025 | 41309872 | PubTator, text mining | PubMed |
| Longitudinal monitoring of autoantibody dynamics in patients with early-stage non-small-cell lung cancer undergoing surgery. | Open Life Sci | 2025 | 41142941 | PubTator, text mining | PubMed |
| NY-ESO-1 targeting in non-small cell lung cancer: promise and challenges of letetresgene autoleucel. | Transl Lung Cancer Res | 2025 | 41132970 | PubTator, text mining | PubMed |
| Innovative therapeutic cancer vaccine PDC∗lung01 with or without anti-PD-1: an open-label, dose-escalation phase I/II study in non-small-cell lung cancer. | ESMO Open | 2025 | 41101155 | PubTator, text mining | PubMed |
| NY-ESO-1 facilitates anoikis resistance and tumor metastasis by hijacking deubiquitinase OTUB1 to stabilize PP1α. | Cell Death Dis | 2025 | 41053024 | PubTator, text mining | PubMed |
| Individualized mRNA Vaccines in Melanoma-Where Do We Stand? | Vaccines (Basel) | 2025 | 41012188 | PubTator, text mining | PubMed |
| ImmuniT Platform for Improved Neoantigen Prediction in Lung Cancer. | Vaccines (Basel) | 2025 | 41012124 | PubTator, text mining | PubMed |
| TCR-T Cell Recognition of an NY-ESO-1 Epitope Presented by HLA-A2 Supertype: Implications for Cancer Immunotherapy. | Vaccines (Basel) | 2025 | 41012104 | PubTator, text mining | PubMed |
| Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout. | Cancers (Basel) | 2025 | 41008910 | PubTator, text mining | PubMed |
| The abscopal effect in metastatic lung cancer: a retrospective analysis of combined radiotherapy and immunotherapy. | Clin Exp Metastasis | 2025 | 41003851 | PubTator, text mining | PubMed |
| Next-Generation mRNA Vaccines in Melanoma: Advances in Delivery and Combination Strategies. | Cells | 2025 | 41002441 | PubTator, text mining | PubMed |
| mRNA Multipeptide-HLA Class II Immunotherapy for Melanoma. | Cells | 2025 | 41002395 | PubTator, text mining | PubMed |
| Development of a PRAME pMHC targeted T cell engager for solid tumor therapy. | MAbs | 2025 | 40994043 | PubTator, text mining | PubMed |
| LTO1 and YAE1 regulate MHC-I expression via nonsense-mediated RNA decay in tumor cells. | J Immunother Cancer | 2025 | 40987494 | PubTator, text mining | PubMed |
| Advances in Adoptive Cell Therapies in Cancer: From Mechanistic Breakthroughs to Clinical Frontiers and Overcoming Barriers. | Med Sci (Basel) | 2025 | 40981188 | PubTator, text mining | PubMed |
| Unlocking new frontiers: novel immune targets for next-generation cancer immunotherapy. | Korean J Clin Oncol | 2025 | 40916400 | PubTator, text mining | PubMed |
| SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8+ T cells to immune checkpoint blockade. | Front Immunol | 2025 | 40909279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/246100/papers?page=4